• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Sunday, February 5, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Mechanism behind deadly fungal infection on top of influenza or Covid-19 deciphered

Bioengineer by Bioengineer
August 24, 2022
in Biology
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Over 15 per cent of all critically ill patients who end up in intensive care with severe influenza or Covid-19 additionally develop aspergillosis, a pulmonary fungal infection. This doubles their mortality rate. A UZ Leuven and KU Leuven trial with international partners has revealed that multiple dysfunctions of the immune response lie at the basis of higher susceptibility to fungal infections. These insights were published in The Lancet Respiratory Medicine and constitute an important first step towards increasing the survival rate of patients with these severe lung infections.

Joost Wauters (KU Leuven/UZ Leuven)

Credit: UZ Leuven

Over 15 per cent of all critically ill patients who end up in intensive care with severe influenza or Covid-19 additionally develop aspergillosis, a pulmonary fungal infection. This doubles their mortality rate. A UZ Leuven and KU Leuven trial with international partners has revealed that multiple dysfunctions of the immune response lie at the basis of higher susceptibility to fungal infections. These insights were published in The Lancet Respiratory Medicine and constitute an important first step towards increasing the survival rate of patients with these severe lung infections.

Every year, hundreds of thousands of people worldwide end up in intensive care with influenza or Covid-19. About 15 per cent of them develop an additional lung infection with the common fungus Aspergillus (aspergillosis). In healthy people, this infection hardly ever leads to illness. For critically ill patients with an underlying influenza or Covid-19 infection, however, aspergillosis can be deadly: the fungus can start to grow in the tissue of their respiratory tract and lungs and cause irreversible damage. The mortality rate of these patients becomes 40%-50%, about twice as high as that of ICU patients who only have severe influenza or Covid-19.

Compromised immune system

To find out why some patients with severe influenza or Covid-19 also develop aspergillosis and what to do about it, UZ Leuven and KU Leuven researchers set up an observational study, together with international colleagues. The study uncovered part of the mechanism that opens the door to an additional fungal infection in patients with an influenza or coronavirus infection.

Prof. dr. Joost Wauters (UZ Leuven/KU Leuven), intensivist at UZ Leuven and the principal investigator of the study, explained: “We discovered that, in patients with serious influenza or Covid-19 who develop this type of fungal infection, the innate immune system had been affected in various areas. Their immune cells, which in healthy people are responsible for eliminating fungal spores in the lungs, were compromised. Furthermore, the white blood cells that would normally clean up fungal hyphae did not seem to function properly in those influenza or Covid-19 patients. It was surprising to see that partly similar deviating immune processes come into play in both Covid-19 and influenza.”

Dr. Simon Feys, internist in training at UZ Leuven and doctoral researcher at KU Leuven, added: “In tissue stainings, we also saw that the corona or influenza virus affects the epithelium of the lungs. This is the layer of cells that lines the respiratory tract and lung tissue, which forms the first barrier against infections. For Covid-19, we were able to show that specifically in the locations where the virus affects the epithelium, the fungus also penetrates the tissue.”

Therapeutic target

Johan Van Weyenbergh (KU Leuven Rega Institute), PhD, who is the co-lead of the study, said: “With this information, we can develop biomarkers that help to predict which patients are more susceptible to a fungal infection and therefore need close follow-up.”

Professor Agostinho Carvalho (University of Braga, Portugal), who also co-led the study, added:  “Our results also lead the way for further research into medication that can repair the affected processes of the immune system and, as a result, suppress the fungal infection.”

More about the study

The study was performed using lung samples of 169 patients with influenza or Covid-19, with or without aspergillosis. Most of the samples were collected over the last couple of years via bronchoalveolar lavage, a classical diagnostic technique for suspected lung infections, and stored in the Leuven biobank.

In 2018, Professor Joost Wauters and his team were the first to report the dangerous combination of aspergillosis and influenza, which led to worldwide vigilance in intensive care units. The current follow-up study now uncovers the mechanism, which will pave the way for the development of biomarkers and modified treatments for patients with this double infection. The corona pandemic made it interesting to include the samples of patients with Covid-19 as well as samples of patients with influenza.

The study was performed in collaboration with various research groups of KU Leuven and UZ Leuven, as well as researchers from ZNA (Belgium), the University of Braga (Portugal), the Max Planck Research Unit for Neurogenetics in Frankfurt (Germany), CHU Amiens-Picardie (France) and the Radboud Universiteit in Nijmegen (The Netherlands). The study was part of the Horizon 2020 HDM-FUN project. 



Journal

The Lancet Respiratory Medicine

DOI

10.1016/S2213-2600(22)00259-4

Method of Research

Observational study

Subject of Research

People

Article Title

Lung epithelial and myeloid innate immunity in influenza associated or COVID-19-associated pulmonary aspergillosis: an observational study

Article Publication Date

24-Aug-2022

Share12Tweet8Share2ShareShareShare2

Related Posts

Salps

Study reveals salps play outsize role in damping global warming

February 3, 2023
Molecular structure of the RepB protein bound to DNA

A protein structure reveals how replication of DNA coding for antibiotic resistance is initiated

February 3, 2023

Voiceless frog discovered in Tanzania

February 3, 2023

Are plastics in the ocean as big a problem as widely believed?

February 3, 2023

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    65 shares
    Share 26 Tweet 16
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Health Equity Report Card pilot project to help close the care gap highlighted on World Cancer Day

Tech that turns household surfaces into touch sensors is a touch closer to application

Preference for naturally talented over hard workers emerges in childhood, HKUST researchers find

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 42 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In